Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis-Reference-Cited by-同舟云学术

Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis

Published:2020-12 Issue: Volume:82 Page:83-89
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Labenz Christian^ORCID,Nagel Michael,Toenges Gerrit^ORCID,Kuchen Robert,Schattenberg Jörn M.^ORCID,Hilscher Max,Huber Yvonne,Marquardt Jens U.,Labenz Joachim,Galle Peter R.,Wörns Marcus-Alexander

Publisher

Elsevier BV

Subject

Internal Medicine

Reference29 articles.

1. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis;Mokdad;BMC Med,2014

2. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the study of liver diseases and the European Association for the study of the liver;Vilstrup;Hepatology,2014

3. [Therapy of acute and chronic hepatic encephalopathy in patients with liver cirrhosis];Ferenci;Z Gastroenterol,1998

4. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy;Bajaj;Gastroenterology,2010

5. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients;Labenz;Aliment Pharmacol Ther,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: Insights into cAMP/PPAR-γ/p-ERK1/2/p S536 NF-κB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories;Biochemical Pharmacology;2024-11

2. Non‐hemodynamic effects: Repurposing of nonselective beta‐blockers in cirrhosis?;Portal Hypertension & Cirrhosis;2022-08-17